9 September 2020 · This article provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD
23 January 2025 · Recommendations for secondary care pharmacy procurement teams to follow before escalating a supply issue or shortage to the SPS Regional Procurement Team.
28 January 2025 · Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input
8 January 2020 · A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012
16 September 2022 · A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland